Misnomer as it is a prothrombotic agent in-vivo<unk>  in-vitro in the<unk> b)
Most patients do not actually have SLE (small proportion develop disease), but SLE patients more likely to develop<unk> 
Included in antiphospholipid syndrome (APS), where there are directed antibodies against membrane anionic phospholipids, or their associated plasma proteins
Increases aPTT
Increases aPTT
Lupus anticoagulant
Too few
Factor VIII inhibitor
Thrombocytopenia
Factor V Leiden
Nonfunctional
Antiphospholipid syndrome
Aspirin